Marc D.  Kozin net worth and biography

Marc Kozin Biography and Net Worth

Director of UFP Technologies

Mr. Kozin has served as one of our directors since 2006. Mr. Kozin served as President of L.E.K. Consulting from 1997 through 2011 and as a Senior Advisor from 2011 through 2018. In December 2022, Mr. Kozin transitioned to the Board of Healthcare Royalty Holdings from that company’s Strategy Advisory Board where he had been serving as chairperson since January 2013. Previously, Mr. Kozin served on the boards of directors of Endocyte (sold to Novartis), Dyax (sold to Shire), Dicerna (sold to Novo Nordisk), Chimerix (sold to Jazz), Frequency Therapeutics (merged with Korro), Flex Pharma (merged with Salarius), VBL Therapeutics (merged with Notable), OvaScience (merged with Millendo), Crunchtime! Information Systems, Medical Simulation Corporation, Brandwise, Advizex, Lynx Therapeutics, Inc., Assurance Medical, Inc., and Isleworth Healthcare Acquisition Corporation.

What is Marc D. Kozin's net worth?

The estimated net worth of Marc D. Kozin is at least $6.33 million as of August 25th, 2026. Mr. Kozin owns 21,112 shares of UFP Technologies stock worth more than $6,332,544 as of August 28th. This net worth approximation does not reflect any other assets that Mr. Kozin may own. Learn More about Marc D. Kozin's net worth.

How do I contact Marc D. Kozin?

The corporate mailing address for Mr. Kozin and other UFP Technologies executives is 100 Hale Street, Newburyport MA, 01950. UFP Technologies can also be reached via phone at (978) 352-2200 and via email at [email protected]. Learn More on Marc D. Kozin's contact information.

Has Marc D. Kozin been buying or selling shares of UFP Technologies?

In the last ninety days, Marc D. Kozin has sold $2,131,500.00 in shares of UFP Technologies stock. Most recently, Marc D. Kozin sold 7,000 shares of the business's stock in a transaction on Tuesday, August 25th. The shares were sold at an average price of $304.50, for a transaction totalling $2,131,500.00. Following the completion of the sale, the director now directly owns 21,112 shares of the company's stock, valued at $6,428,604. Learn More on Marc D. Kozin's trading history.

Who are UFP Technologies' active insiders?

UFP Technologies' insider roster includes R. Bailly (Chairman and Chief Executive Officer), Steve Cardin (Vice President, Chief Operating Officer, MedTech), Daniel Croteau (Director), Cynthia Feldmann (Director), Jason Holt (Chief Commercial Officer), Symeria Hudson (Director), Marc Kozin (Director), Ronald Lataille (Sr. Vice President, Treasurer and Chief Financial Officer), Christopher Litterio, Esq (General Counsel and Sr. Vice President of Human Resources), Thomas Oberdorf (Director), and Mitchell Rock (President). Learn More on UFP Technologies' active insiders.

Are insiders buying or selling shares of UFP Technologies?

In the last twelve months, insiders at the industrial products company sold shares 10 times. They sold a total of 31,912 shares worth more than $9,532,116.07. The most recent insider tranaction occured on August, 25th when Director Marc D Kozin sold 7,000 shares worth more than $2,131,500.00. Insiders at UFP Technologies own 4.6% of the company. Learn More about insider trades at UFP Technologies.

Information on this page was last updated on 8/25/2026.

Marc D. Kozin Insider Trading History at UFP Technologies

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
8/25/2026Sell7,000$304.50$2,131,500.0021,112View SEC Filing Icon  
3/8/2021Sell10,000$54.10$541,000.0040,900View SEC Filing Icon  
3/10/2020Sell4,933$46.06$227,213.9845,337View SEC Filing Icon  
9/10/2019Sell2,610$39.92$104,191.2034,176View SEC Filing Icon  
See Full Table

Marc D. Kozin Buying and Selling Activity at UFP Technologies

This chart shows Marc D Kozin's buying and selling at UFP Technologies by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

UFP Technologies Company Overview

UFP Technologies logo
UFP Technologies, Inc. designs and manufactures solutions for medical devices, sterile packaging, and other highly engineered custom products. The company offers protective drapes for robotic surgery, single patient use surfaces, advanced wound care, infection prevention, disposables for surgical and endoscopic procedures, packaging for medical devices, orthopedic implants, biopharma drug manufacturing, and coils for catheters; and molded components for applications in acoustic insulation, interior trim, load floors, sunshades, SUV cargo cover handles, driveshaft damping, engine and manifold covers, quarter panels, and wheel liners. It also provides molded composites for commercial aviation and military gear for use in backpack components, knee and elbow pads, eyewear, and helmets; and reusable cases and custom for applications in military ballistics panels, virtual training systems, drones, communications equipment, and rugged portable computers. In addition, the company provides engineered products and components to customers in the automotive, aerospace and defense, and industrial markets for applications in military uniform and gear components, automotive interior trim, air filtration, and protective cases and inserts. It markets and sells its products through a direct sales force. The company was founded in 1963 and is headquartered in Newburyport, Massachusetts.
Read More

Today's Range

Now: $299.95
Low: $298.64
High: $305.53

50 Day Range

MA: $274.01
Low: $230.11
High: $334.84

2 Week Range

Now: $299.95
Low: $173.86
High: $338.71

Volume

102,272 shs

Average Volume

176,309 shs

Market Capitalization

$2.32 billion

P/E Ratio

32.32

Dividend Yield

N/A

Beta

1.08